Literature DB >> 16876999

Towards a crucial role for DC-SIGN in tuberculosis and beyond.

Olivier Neyrolles1, Brigitte Gicquel, Lluís Quintana-Murci.   

Abstract

The C-type lectin DC-SIGN has recently received considerable attention in the context of tuberculosis and other infectious diseases. Clinical investigations, together with genetic association studies, strongly support the notion that variation in the level of expression of DC-SIGN - but not changes in the structure of the protein - might have a strong impact on the susceptibility to and pathogenesis of several infectious diseases, including tuberculosis. In addition, efforts to decipher the evolutionary history of the gene encoding DC-SIGN clearly demonstrated that this gene is under strong selective constraints that have prevented the accumulation of amino acid changes over time. Altogether, these findings suggest that DC-SIGN might play a crucial part in host immunity to pathogens and possibly beyond, at an early stage of human development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876999     DOI: 10.1016/j.tim.2006.07.007

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  10 in total

Review 1.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

Review 2.  Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat.

Authors:  James V Falvo; Shahin Ranjbar; Luke D Jasenosky; Anne E Goldfeld
Journal:  Am J Respir Cell Mol Biol       Date:  2011-08-18       Impact factor: 6.914

3.  Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN.

Authors:  Nicole N Driessen; Roy Ummels; Janneke J Maaskant; Sudagar S Gurcha; Gurdyal S Besra; Gary D Ainge; David S Larsen; Gavin F Painter; Christina M J E Vandenbroucke-Grauls; Jeroen Geurtsen; Ben J Appelmelk
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

Review 4.  Early T-cell responses in tuberculosis immunity.

Authors:  Gary M Winslow; Andrea Cooper; William Reiley; Madhumouli Chatterjee; David L Woodland
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

5.  Cyanovirin-N inhibits mannose-dependent Mycobacterium-C-type lectin interactions but does not protect against murine tuberculosis.

Authors:  Nicole N Driessen; Helena I M Boshoff; Janneke J Maaskant; Sebastiaan A C Gilissen; Simone Vink; Astrid M van der Sar; Christina M J E Vandenbroucke-Grauls; Carole A Bewley; Ben J Appelmelk; Jeroen Geurtsen
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

Review 6.  Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction.

Authors:  Arun K Mishra; Nicole N Driessen; Ben J Appelmelk; Gurdyal S Besra
Journal:  FEMS Microbiol Rev       Date:  2011-05-31       Impact factor: 16.408

7.  Evolutionary genetics as a tool to target genes involved in phenotypes of medical relevance.

Authors:  Evelyne Heyer; Lluis Quintana-Murci
Journal:  Evol Appl       Date:  2009-02       Impact factor: 5.183

8.  The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to Mycobacterium tuberculosis.

Authors:  Geanncarlo Lugo-Villarino; Anthony Troegeler; Luciana Balboa; Claire Lastrucci; Carine Duval; Ingrid Mercier; Alan Bénard; Florence Capilla; Talal Al Saati; Renaud Poincloux; Ivanela Kondova; Frank A W Verreck; Céline Cougoule; Isabelle Maridonneau-Parini; Maria Del Carmen Sasiain; Olivier Neyrolles
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

9.  A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis.

Authors:  Antoine Tanne; Bo Ma; Frédéric Boudou; Ludovic Tailleux; Hélène Botella; Edgar Badell; Florence Levillain; Maureen E Taylor; Kurt Drickamer; Jérome Nigou; Karen M Dobos; Germain Puzo; Dietmar Vestweber; Martin K Wild; Marie Marcinko; Peter Sobieszczuk; Lauren Stewart; Daniel Lebus; Brigitte Gicquel; Olivier Neyrolles
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

10.  Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection.

Authors:  Renato Ribeiro-Viana; Macarena Sánchez-Navarro; Joanna Luczkowiak; Julia R Koeppe; Rafael Delgado; Javier Rojo; Benjamin G Davis
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.